Eusol Biotech Co., Ltd. (6652)
Market Closed
9 Apr, 06:59
TWSE 
JPX Primary TWSE NT$
1. 96
0
0%
NT$
- Market Cap
- P/E Ratio
130% Div Yield
7.49M Volume
- Eps
NT$ 1.96
Previous Close Want to track 6652 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Eusol Biotech Co., Ltd. (6652) Statistics
Valuation metrics
Market Cap -
Enterprise value 88.28M
Trailing P/E (ttm) -6.53
Forward P/E -
PEG ratio 0.2
Price/Sales (ttm) 129.28
Price/Book (mrq) 0.81
Enterprise Value/Revenue 42.5
Enterprise Value/EBITDA -2.11
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) 2.86M
Price summary
52-Week low 1.87
52-Week high 10.2
Beta -
50-Day moving average -
200-Day moving average 5.81
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Nov 2025
Ex-Dividend Date 29 Sep 2025
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -19.46%
Operating margin -22.67%
Operational effectiveness
Return on assets -0.12%
Return on equity -0.12%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.3
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.2
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 31.59%
Book value per share (mrq) 2.41
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
